Top 5 Wellness Startup Investors in Taiwan in January 2026

Last updated: Jan 2026 A list of 5 angel investors and VC (Venture Capital) funds that invest in Wellness startups based in Taiwan. We rank investors based on the number of investments they made in Wellness companies from Taiwan. We update this investor list every month.

Top 5 Wellness Startup Investors in Taiwan in January 2026

Investor	Wellness Taiwan investments
Yan Jin	1
Zero2IPO Ventures	1
Sino Biopharmaceutical	1
Suzhou Industrial Park Nankai Venture Capital	1
Panacea Venture	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Yan Jin has 15-year venture capital, investment banking, and corporate management experience covers more than 20 investment projects, involving consumer electronics, new materials, the Internet, and innovative services industries. Ms. Jin also serves as a leader of China’s Democratic National Construction Party, a political party separate from theCommunist Party of China. She is currently a legislative member of the Shenzhen Municipal Government. Ms. Jin is also a cofounder of Shenzhen Capital Group.

Investment focus

Fitness, mHealth, Wellness
Series A
Taiwan

Portfolio highlights

iFit — iFit (爱瘦身) is a website and mobile community that focuses on health and slimming services.iFit currently emphasizes on content, communities, and electronic commerce services. It plans on expanding its services into wearable equipment, application software, hardware services, and more. In March 2013, iFit gathered pictures and articles andpublished a book named Get Food not Fat, which was on the best-selling list once released. At the same time, IFit entered the group buying market.iFit was founded by Chen Yunru in June 2012. She started her business through a fan club by sharing her own experiences of losing weight. In less than a year her fan base reached more than 400,000. The official iFit website was set up in December 2012.

Zero2IPO Ventures is the venture investment arm under Zero2IPO Group targeted at high-potential, high-growth China enterprises. Leveraging Zero2IPO's vast network in China, Zero2IPO Ventures does not compete with other venture funds, but rather pursue a two-prong investment strategy, i.e. to co-invest with active venture capital firms ingrowth and late stage companies and to lead or co-lead in early stage startups in China. The industry focus includes Internet, mobile and wireless applications, digital media, healthcare, green-tech, consumable products and services, as well as other emerging sectors. We intend to leverage the extensive network that has been created by Zero2IPO Group, a leading venture capital and private equity market research and financial advisory company, to seek out potential investment opportunities and provide a strong value-add to our portfolio companies. Through its venture capital and private equity surveys, investment forums, training programs, and investment advisory services, Zero2IPO Group has developed a strong reputation in the China market for helping entrepreneurs connect with investors.

Investment focus

E-Commerce, Internet, Education
Series A, Series B, Angel
China, India, Taiwan

Portfolio highlights

AlpsenTek — AlpsenTek is a company engaged in the research and development of machine vision sensors and algorithms.
HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Reistone Biopharma — Reistone Biopharma is a clinical stage biopharmaceutical company. It is focused on rapidly developing innovative medicines through global collaborations within Research and Development

Sino Biopharmaceutical engages in pharmaceutical products which covers an array of R&D platforms, a line-up of intelligent production and a strong sales system. The Group's products have gained a competitive foothold in various therapeutic categories with promising potentials, comprising a variety of biopharmaceutical and chemicalmedicines for treating tumours, liver diseases, cardio-cerebral diseases, analgesia, respiratory system diseases and orthopedicdiseases.

Investment focus

Biotechnology, Health Care, Manufacturing
Series D, Series B, Series E
China, United States, Israel

Portfolio highlights

Medlinker — Medical Alliance is a post of physician social service platform. Users are certified doctors working in the Medical Alliance, they can share knowledge, experience and insights with the other industry elite, to continue to provide high quality content for each other. Application provides a medical quiz, map that case, the anonymous social circlesand doctors and other functions, is committed to helping physicians groups, more convenient access to high-quality information from the industry
HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.
Generon (Shanghai) Corporation — Generon (Shanghai) Corporation Ltd. is an integrated biotech company developing therapeutic biologics for patients world-wide. Their research & development center is located in Zhang Jiang High-Tech Park, Shanghai, China. their cGMP drug manufacturing facility is located in Economic-Technological Development Area, Beijing, China. Theirmission is “Innovating for Life” to develop innovative therapeutic biologics for global patients with unmet medical needs. They employ their proprietary, cutting-edge technology platforms to discover, develop and manufacture biologic therapeutics. They are focused on “best-in-class” and “first-in-class” recombinant therapeutic proteins to treat cancer, autoimmune and inflammatory diseases. They follow international quality standards for their product development and adhere to regulatory requirements of the CFDA, FDA and EMA. “Innovation and quality” are the soul of Generon in the generation of scientific data and in the processes of drug discovery, development and manufacturing.

Suzhou Industrial Park Nankai Venture Capital is engaged in venture capital business.

Investment focus

Wellness, Health Care, Consumer Research
Series A
Taiwan

Portfolio highlights

HanchorBio — HanchorBio is a Biotechnology Research firm that is working to revolutionize the treatment of people with cancer.

Discover Panacea Venture - a global healthcare fund driving innovation in biotech. Transforming lives through investments. Explore our portfolio and strategy.